pubmedbert-e51ebef7·2 events·first seen Aliases: PubMedBERT
Researchers from CaresAI evaluated biomedical transformer models (ClinicalBERT, PubMedBERT, BioBERT, MedCPT) for detecting dosing errors in clinical trial protocols, combining text embeddings with structured metadata and classical ML classifiers. BioBERT achieved the best single-encoder performance at ROC-AUC 0.794, while gradient boosting and SVM ensembles reached 0.821–0.853. The study finds that domain alignment of the encoder matters more than stacking multiple embeddings, and demonstrates a practical NLP pipeline for clinical trial safety monitoring.
Researchers identify a critical failure mode in biomedical language model embeddings: off-the-shelf encoders (BioBERT, PubMedBERT, BioM-ELECTRA) assign high cosine similarity (0.76–0.92) to causally unrelated cross-domain pairs, achieving 0% accuracy on cross-domain discrimination. The paper introduces BODHI, a contrastive training approach using hard negatives mined from a biomedical knowledge graph, which improves within-vs-across-domain separation from 1.05x to 2.30x and raises discrimination gap by +0.392. The work targets Large Behavioural Models (LBMs)—foundation models that reason over personal life graphs—where false embedding proximity directly produces false causal edges. Additional contributions include an OpenVINO inference optimization achieving 133x latency reduction (1367ms to 10ms) on Intel AMX hardware, plus a counterintuitive finding that FP16 outperforms INT8 on this silicon.